SPUR™ diagnostic tool
Just as medical diagnoses allow people to decide on an appropriate course of treatment, behavioral diagnoses allow to understand where the patient is with their health, personalize patient support, and encourage shared medical decision-making. That is we’ve created a proprietary behavioral diagnostic tool: SPUR™.
SPUR™ is the only available validated tool for deciphering patients’ reasons for non-adherence. It is a dynamic and predictive digital-by-design questionnaire that harnesses decades of behavioral science.
With answers to a few questions, SPUR™ creates a holistic behavioral profile that describes patients’ health behaviors along four dimensions: social, psychological, usage, and rational.
SPUR™ is unique in its capacity to deliver robust and actionable data on patients’ behavior—in any therapeutic area or cultural context.
Delivering 3 tested and validated outcomes
SPUR™ is already used on over 40,000 patients in 27 therapeutic areas (e.g., asthma, hypertension, breast cancer, multiple sclerosis, Type 2 diabetes). Seven scientific publications have validated that it delivers three helpful outputs for healthcare providers:
- Risk of non-adherence
- Holistic behavioral profile that examines four dimensions and 13 drivers
- Actionable tips for caregivers
SPUR™ use cases
Clinical development
Market research
Patient experience
Medical practice
Research
Clinical development
I’m a CRO, a sponsor, a Clinical development lead and I want to reduce clinical dropouts
With clinical trials on average losing 30% of their participants, dropout rates are a critical issue for researchers to address. Dropping out of a clinical trial is a health behavior. Patients who choose to stop participating in a trial always have reasons for doing so. SPUR™ makes it possible to examine patients’ social determinants of health, quantify their risk of dropping out, and identify their risk factors. You can use that information to personalize your patient interactions and, if necessary, interventions to reduce non-adherence to protocol’s design.
Market research
I’m on a pharma marketing team and I want to understand a patient population
SPUR™ is particularly powerful as a market research tool. Leveraged in Observia’s patient journey mapping methodologies, SPUR™ helps deepen your understanding of your patient population’s attitudes and health behaviors.
SPUR™ in Patient Journey MappingPatient experience
I’m on a pharma Digital / Patient experience team and I want to personalize a patient service
As a digital native tool, SPUR™ provides data that are ready for any program to use for behavior-based personalization. In our view, the best way to keep a chronic patient engaged throughout their journey and help them cultivate the best habits to improve their quality of life is to tailor support to their individual needs. SPUR™ supplies the foundation for truly personalized, impactful, and patient-centric digital services and unlocks the cutting-edge of patient-centric technology.
I work on patient centricity or digital innovation, and I want to integrate SPUR™ in my existing patient service APIs
SPUR™ can easily be plugged into existing technical environments and enable collecting objective behavioral patient data or monitoring a solution’s behavioral impact. We only need to know your therapeutic area to customize SPUR™ for your use.
How to personalizeMedical practice
I’m a healthcare professional and I want to use SPUR™ in my medical practice
You understand your patients better than a machine can. However, time is a precious resource in healthcare, and patients’ health behaviors are complex. SPUR™ can help collect objective behavioral data. For HCPs’ specific use, we developed SPUR4Care.
SPUR™ for HCPsResearch
I’m a researcher and I want to use SPUR™ in my research studies
We developed SPUR™ as a novel patient reported outcome measure (PROM) to better understand medical adherence and its drivers across a variety of chronic diseases and cultures. The SPUR adherence model and tool continue to be tested and proven effective for different pathologies, geographies, and languages. If patient behavior is at the heart of your research, SPUR™ is the right tool for you. With just one online questionnaire, you’ll be able to examine 18 points of data, risk of non-adherence, four dimensions, and 13 drivers.
SPUR™ for researchAn effortless Patient Experience
Completed in 2-3 minutes
User friendly interface
Personalized feedback
95% of completion rate
Validation
We long wondered why a patient would not adhere to treatments that could benefit them the most, but couldn’t find the right tool for answering the question.
Determined to find answers, in 2017, we began the research and development that eventually produced SPUR™.
- Phase 0 established our model’s academic foundations through a literature review, a board review, and the elaboration of a decision-making framework.
- Phase 1 had two objectives: identifying the questions to be included in SPUR™ and evaluating the questionnaire’s psychometric properties. We conducted a literature review, a board review, and qualitative interviews with patients with diabetes, COPD, breast cancer, and multiple sclerosis.
- Phase 2’s goals were to validate the SPUR tool’s final structure and predictive power with real-life adherence data through MPR via a multi-country quantitative analysis of Type 2 diabetes and a multi-pathology approach.
Seven scientific publications (in such journals as Patient Preference and Adherence, the British Medical Journal, and Current Medical Research and Opinion) have validated the predictive power of SPUR™. Presenters at different European conferences, including the Health Services Research and Pharmacy Practice conference, and those of the International Society for Medication Adherence (ESPACOMP), the Institute of Molecular and Cellular Biology (IBMC), and the European Association for the Study of Diabetes, have also discussed SPUR™.